Skip to content

Clinical trials

Phase 1 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 1 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20162
20191
20206
20212
20232
20243
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Not yet recruiting5
Terminated2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital3
AdAlta Limited2
GlaxoSmithKline2
Mayo Clinic2
Baylor Research Institute1
Black Tie Medical, Inc.1
Bristol-Myers Squibb1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Children's Hospital of Fudan University1
Li Shiyue1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial27
Idiopathic Pulmonary Fibrosis4
Pulmonary Fibrosis4
Pulmonary Disease, Chronic Obstructive3
Asthma2
Bronchiectasis2
Connective Tissue Diseases2
Cystic Fibrosis2
Fibrosis2
Hypertension, Pulmonary2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.